Latest News
QV Bioelectronics Delivers Breakthrough Pre-Clinical Safety and Efficacy Results for Electric Field Therapy in the treatment of Glioblastoma
Safety of QV’s novel stimulation regimes demonstrated in large animal studies for up to three months of implantation. Pre-clinical data…
Read MoreQV Bioelectronics secures £343,000 from Innovate UK’s Cancer Therapeutics programme to develop a new treatment for childhood brain tumours.
Press Release The project will adapt QV Bioelectronics’ existing electric field therapy (EFT) technology to develop the world’s first fully…
Read MoreQV Bioelectronics and Incubate Bio announce successful outcome of strategic collaboration to accelerate new treatment option for Glioblastoma
Collaboration delivered vital insights to advance revolutionary treatment modality – GRACE ALaSCA platform able to decipher experimental data from complex…
Read MoreMichaela Joins QV as Summer Intern
Exciting News: Welcome Michaela Baek, Our New Summer Intern at QV Bioelectronics! ? Michaela, an aspiring biologist, is eager to…
Read MoreQV Bioelectronics selected for TMC inaugural UK cohort
QV Bioelectronics are one of 16 leading digital health and medical device startups founded in the UK have been selected…
Read MorePress Release: QV Bioelectronics Awarded £860,000 Innovate UK Boost.
QV Bioelectronics Awarded £860,000 Innovate UK Boost. Funds awarded under Combined Investor Partnerships by Innovate UK, the UK’s innovation agency….
Read More